Nexalin Technology (NXL) Non Operating Income (2021 - 2026)
Nexalin Technology (NXL) posted Non Operating Income of $8145.0 for Q2 2026, down 64.69% on a QoQ basis from $23065.0 in Q1 2026, and down 79.57% year-over-year from $39871.0 in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Non Operating Income (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Non Operating Income for 6 years, with the latest figure at $8145.0 in Q2 2026.
- On a quarterly basis, Non Operating Income fell 79.57% year-over-year to $8145.0 in Q2 2026; TTM through Jun 2026 was $137151.0, a 17.29% decrease from a year earlier, with the FY2025 full-year figure at $169748.0, up 19.03% from the prior year.
- Non Operating Income was $8145.0 for Q2 2026 at Nexalin Technology, down from $23065.0 in the prior quarter.
- The five-year high for Non Operating Income was $843804.0 in Q4 2023, with the low at -$18132.0 in Q1 2022.
- Average Non Operating Income over 5 years is $83525.4, with a median of $33816.5 recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income jumped 8487.71% in 2023, then tumbled 95.03% in 2024.
- Over 5 years, Non Operating Income stood at -$10060.0 in 2022, then surged by 8487.71% to $843804.0 in 2023, then sank by 95.03% to $41921.0 in 2024, then slipped by 12.64% to $36621.0 in 2025, then tumbled by 77.76% to $8145.0 in 2026.
- The last three Non Operating Income figures came in at $8145.0 (Q2 2026), $23065.0 (Q1 2026), and $36621.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | - |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 8,145.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,145.00 |
| Mar 31, 2026 | 23,065.00 |
| Dec 31, 2025 | 36,621.00 |
| Sep 30, 2025 | 69,320.00 |
| Jun 30, 2025 | 39,871.00 |
| Mar 31, 2025 | 23,936.00 |
| Dec 31, 2024 | 41,921.00 |
| Sep 30, 2024 | 60,101.00 |
| Jun 30, 2024 | 13,819.00 |
| Mar 31, 2024 | 26,772.00 |
| Dec 31, 2023 | 843,804.00 |
| Sep 30, 2023 | 118,348.00 |
| Jun 30, 2023 | 54,423.00 |
| Mar 31, 2023 | 31,012.00 |
| Dec 31, 2022 | -10,060.00 |
| Sep 30, 2022 | 157,793.00 |
| Jun 30, 2022 | -17,302.00 |
| Mar 31, 2022 | -18,132.00 |
| Dec 31, 2021 | -18,439.00 |
| Sep 30, 2021 | -4,259.00 |